Indications for ERNA
| Valvular heart disease |
| Timing of surgery |
| Assessment of treatment effect |
| Cardiomyopathy |
| Evaluation of biventricular function |
| Determination of type (systolic vs. diastolic) and severity |
| Assessment of diastolic dysfunction |
| Identification of candidates for defibrillator implantation andresynchronization therapy |
| Evaluation of ventricular function before and after transplantation |
| Cardio‐oncology |
| Monitoring LV function during chemotherapy |
| Diagnosis of cardiotoxicity from chemotherapy |
| Guiding chemotherapy |
| Uncommon indications |
| Stable coronary artery disease* |
| Diagnosis (rest/stress ERNA) |
| Prognosis |
| Assessment of treatment efficacy |
| Adjunctive evaluations |
| Evaluation of RV function |
| Determination of ventricular dyssynchrony |
↵* Performance of stress ERNA (exercise or dobutamine) in the setting of acute coronary syndromes is not recommended.